Empagliflozin directly improves diastolic function in human heart failure

Given the influence of empagliflozin on reduced mortality and hospitalization for heart failure (HF) compared to placebo, researchers sought the possible direct myocardial effects of empagliflozin. They performed contractility experiments with in toto-is https://www.mdlinx.com/journal-summaries/heart-failure-empagliflozin-diastolic-dysfunction-contractility/2018/10/24/7547606/